The Global Bioinformatics Market: Market size, forecasts and company profiles

The Global Bioinformatics Market: Market size, forecasts and company profiles published by Business Insights in September, 2009. This report consists of 266 pages and the price starts from US $ 3835.

Introduction

Abstract

Introduction

The integration of biology and informatics has been very integral part of the life science applications. Changing trends in the drug discovery procedures such as strict regulations in the clinical testing have forced the drug manufacturers to use effective technologies that will help them to develop successful therapies. The market players are collaborating with each other to develop block buster technologies while utilizing this synergy to reduce cost.

This report has covered different regional markets, products and services while evaluating them over the next five years. It provides the information about the largest regional market and factors influencing them, while defining the opportunities they have.

Scope of this report

• It analyzes the market data ( revenues ) of bioinformatics tools, services and content/database in North America, Europe, Asia and rest of the world that includes Middle East, Africa, Russia, Latin America and Australia
• Key market drivers, restraints and opportunities for the parent segments and evaluation of respective sub segments with respect to market dynamics.
• Covers sequence analysis, sequence alignment, sequence manipulation and structural analysis under tools market along with the sub segments. Service market includes data analysis, database and management and sequencing services.
• Provides patent analysis with respect to competitors, geography and technology while analyzing them over the years.
• Describes the strategic focus of the market players by evaluating the competitive landscape within the bioinformatics market.
• Analyze the markets while giving an overview of Indian and Chinese bioinformatics industry and mutually comparing them.

Key findings from this report

• The bioinformatics market growth is highest in the Europe and Asian region, with the European market estimated to compete in the North American bioinformatics market.
• North America constitutes the major market share owing to growing demand for bioinformatics tools and technology advancements.
• European bioinformatics market is undergoing fast transition from a fragmented market to a consolidated market owing to increasing number of mergers and acquisition taking place.
• Sequence analysis tools forms the largest market of the total tools market with its large number of applications in the drug discovery.
• Large bioinformatics firms such as Affymetrix and Invitrogen are focusing on acquisitions in order to add more to their product and service portfolio.
• Data analysis and sequencing services form the major segment in the bioinformatics service market. Rise in the consultancy services has been the major driving force behind the market growth.

Use this report to:

• Understand the emerging technologies and the growth associated for evaluation of potential of the type of product and services.
• Understanding the product developments on which the companies are focussing for evaluating the new technological trends.
• For evaluation of growth prospective for the bioinformatics applications and determining the lucrative markets.
• To gain knowledge about the relative importance of the bioinformatics tools in the next five years for investment opportunities.
• Helps in determining the market players' interest in terms of collaborations and M&A with the related industrial firms which will help a company to explore the untouched areas.
• Gives an explanatory overview of business environment between India and China, thereby putting an opportunity for the companies to focus on weak business areas.

Table of Contents

Executive summary

• Market overview
• Competitive landscape & market dynamics
• The bioinformatics tools market
• The bioinformatics
• The bioinformatics service market
• The bioinformatics
• Regional analysis of the bioinformatics
• Company profiles

Chapter 1 - Market overview

• Summary

• Introduction
• Defining the bioinformatics market
• Market evolution increases use of bioinformatics

• Bioinformatics and drug development
• Sequencing tools are high priority
• Bioinformatics database management tools

• Bioinformatics patent analysis
• Genomics remains the key segment
• High market presence of Japanese market players
• Bioinformatics service outsourcing shifting to Asian markets

• Market Size

Chapter 2 - Competitive landscape & market dynamics

• Summary
• Introduction

• Competitive landscape
• Recent mergers and acquisitions
• Recent product, technology and service launches

• Market drivers
• Need for integrated data-handling tools for drug discovery
• Growth in genomics and proteomics industry
• Wide applications in drug discovery and development
• Government support for R&D
• Biomarker discovery enables the development of safe drugs
• Developments in internet and IT
• Emergence of high-throughput screening
• Other drivers

• Resistors of market growth
• Common, well-defined data formats are needed
• Need for trained resources compound operational costs
• Saturation of pharmaceutical markets reduces adoption rate
• Restricted range of product/service offerings
• Other restraints to market growth

• Growth opportunities
• Pressure to escalate drug research productivity
• Drug development value chain to widen opportunities
• High market demand for integrated systems and solutions
• Chemogenomics poses vast opportunity for growth
• Applications in diversified areas to expand the user base
• Data overload in the field of research

Chapter 3 - The bioinformatics tools market

• Summary

• Introduction
• Growth drivers
  • Need for better output quality in drug discovery
  • Integration of bioinformatics resources
  • Application of bioinformatic tools in the life sciences market
• Resistors of growth
  • Complex operations of bioinformatic tools restricts growth
  • High price of analytical solutions may not be feasible

• Sequence analysis tools
• DNA sequence analysis tools
  • Sequence alignment
  • Gene detection
  • Restriction, and repeats and unusual patterns detection
  • Transcriptional elements detection
  • tRNA detection
• Protein function assignment
  • Protein-protein interaction
  • Pattern, motif, profiles, domains and families search
  • Search, computation and analysis of pathways
  • Protein annotation
  • Automatic alerts for related new sequences
• 3D structure analysis and modeling tools
  • 3D viewers
  • 3D homology modeling
  • 3D analysis
• RNA analysis tool
• Microarray data analysis
• Phylogenetic analysis
  • Multiple sequence alignment
  • Organism classification

• Sequence alignment tools
• Sequence analysis (alignment)
  • Multiple sequence alignment
  • Phylogenetic tree building
  • Consensus sequence and translation
• Lab end-sequence analysis
  • Primer design
  • Cloning
  • Contig assembly

• Sequence manipulation tools
• Sequence analysis (including sequence manipulation)
• Sequence manipulation
• Format conversion
• Random sequences

• Structural analysis tools
• Sequence visualization tools
  • 3D protein structure
  • Dot plots
  • Graphical and phylogenetic tree viewers and editors
• Primary sequence analysis
• Physicochemical property alignment
• Alignment tools
• Predicting secondary structure sequences

• Other bioinformatics tools
• Visualization tools
  • Database viewers
  • Sequence viewers
  • Molecular viewers
• Physical mapping software

Chapter 4 - The bioinformatics content/database market

• Summary

• Introduction
• Growth drivers
  • Exponential growth in the proteomics data and databases
  • Data integration devices needed for in-house solutions
  • Growth in the clinical trials industry supports the market

• Specialized databases
• Specialized sequence databases
• Genome databases
  • Collections
  • Model organism databases
• Specialized protein databases
  • Proteome databases
  • Protein classification databases
  • Specific protein family databases
• Specialized structural databases
• Microarray databases
• Pathways databases
• 2D-PAGE databases

• General databases
• Primary sequence databases
• Protein sequence databases
• 3D structure databases
• Carbohydrate databases

Chapter 5 - The bioinformatics services market

• Summary

• Introduction
• Growth drivers
  • Growing trend towards consultancy
  • Requirement for highly efficient data-mining tools
  • Need for total integration & warehousing solutions

• Data analysis services
• Genomics data analysis
• Proteomics data analysis
• Microarray data analysis
• Modeling & computational bioinformatics services

• Sequencing services
• High-throughput screening
• Multiple sequence alignment
• Resequencing (SNP profiling)
• Primer walking
• Expression profile clustering
• Shotgun sequencing

• Database management services
• Conception and realization
• Development of user interface
• Maintenance
• Backup systems
• Migration

• Other services
• Security systems
• Data-mining services
• Infrastructure integration services
• Knowledge management

Chapter 6 - The bioinformatics applications market

• Summary

• Introduction
• Global market dynamics
• Growth drivers
  • Rapid development of molecular diagnostics market
  • Development in personalized medicine
  • Specific medicines developed to treat the source of disease
• Resistors of growth
  • Need for more holistic solutions
  • Bioinformatics considered to be for specialized applications only
• Opportunities
  • Application in the military
  • Bioinformatics in epidemiology
  • Integration of systems biology with bioinformatics

• Molecular medicine
• Global market
  • US
  • Europe
  • Asia

• Preventive medicine

• Gene therapy
• Growth drivers
  • Biomarker discovery helps gene therapy to determine disease candidates
  • Demand for gene therapy treatment necessitates bioinformatics application
• Opportunities
  • Data proliferation in the field of gene therapy
  • Declining growth of gene therapy market

• Drug development
• Growth drivers
  • Drastic cost reduction in the process of drug discovery
  • Data processing needs in the drug development process
• Virtual high-throughput screening
• Sequence analysis
• Similarity searches
• Drug lead optimization
• Physicochemical modeling
• Drug bioavailability and bioactivity

• Other applications

Chapter 7 - Regional analysis of the bioinformatics market

• Summary
• Introduction
• North America
• Europe

• Asia
• India and China
  • The Indian bioinformatics industry
  • Business opportunities in India and China
  • Growth drivers
  • Growth resistors

• Rest of the World

Chapter 8 - Company profiles

• Summary

• 3rd Millennium Inc.
• Company overview
• Products and services
• Company strategy

• Accelrys, Inc.
• Company overview
• Products and services
• Company strategy
• Affymetrix
• Company overview
• Products and services
• Company strategy

• Agilent Technologies, Inc.
• Company overview
• Products and services
• Company strategy
• Animech Technologies AB
• Company overview
• Products and services
• Company strategy

• Bruker Daltonics inc.
• Company overview
• Products and services
• Company strategy

• Ariadne Genomics
• Company overview
• Products and services
• Company strategy

• Biobase GmbH
• Company overview
• Products and services
• Company strategy

• BioDiscovery, Inc.
• Company overview
• Products and services
• Company strategy

• Bioinformatics Solutions Inc.
• Company overview
• Products and services
• Company strategy

• Biomatters Ltd.
• Company overview
• Products and services
• Company strategy

• Biomax Informatics AG
• Company overview
• Products and services
• Company strategy

• BioWisdom Ltd.
• Company overview
• Products and services
• Company strategy

• Celera Genomics Corporation
• Company overview
• Products and services
• Company strategy

• CLC bio
• Company overview
• Products and services
• Company strategy

• Geospiza, Inc.
• Company overview
• Products and services
• Company strategy

• Clontech Laboratories, Inc.
• Company overview
• Products and services
• Company strategy

• Definiens AG
• Company overview
• Products and services
• Company strategy

• DNASTAR, INC.
• Company overview
• Products and services
• Company strategy

• Expression Analysis, Inc.
• Company overview
• Products and services
• Company strategy

• Gene Logic
• Company overview
• Products and services
• Company strategy

• Genedata AG
• Company overview
• Products and services
• Company strategy

• GeneGo
• Company overview
• Products and services
• Company strategy

• Geneva Bioinformatics SA
• Company overview
• Products and services
• Company strategy

• Genologics Life Sciences Software
• Company overview
• Products and services
• Company strategy

• Genomatix Software Inc.
• Company overview
• Products and services
• Company strategy

• GenomeQuest, Inc.
• Company overview
• Products and services
• Company strategy

• Helicos Biosciences Corporation
• Company overview
• Products and services
• Company strategy

• Illumina Inc.
• Company overview
• Products and services
• Company strategy

• InforMax Inc.
• Company overview
• Products and services
• Company strategy

• Nucleics Pvt Ltd.
• Company overview
• Products and services
• Company strategy

• Inforsense Limited
• Company overview
• Products and services
• Company strategy

• Kinexus Bioinformatics Corporation
• Company overview
• Products and services
• Company strategy

• MDS Inc.
• Company overview
• Products and services
• Company strategy

• Miraibio Group
• Company overview
• Products and services
• Company strategy

• Golden Helix, Inc.
• Company overview
• Products and services
• Company strategy

• Invitrogen Corporation
• Company overview
• Products and services
• Company strategy

• Molegro
• Company overview
• Products and services
• Company strategy

• Nonlinear Dynamics
• Company overview
• Products and services
• Company strategy

• Textco Biosoftware, Inc.
• Company overview
• Products and services
• Company strategy

• Numerical Algorithms Group Ltd.
• Company overview
• Products and services
• Company strategy

• Ocimum Biosolutions Ltd.
• Company overview
• Products and services
• Company strategy

• Partek Inc.
• Company overview
• Products and services
• Company strategy

• Phase Forward Inc.
• Company overview
• Products and services
• Company strategy

• Premier Biosoft International
• Company overview
• Products and services
• Company strategy

• Protein Forest Inc.
• Company overview
• Products and services
• Company strategy

• Rosetta Biosoftware
• Company overview
• Products and services
• Company strategy

• Silicon Graphics Inc.
• Company overview
• Products and services
• Company strategy

• Softberry Inc.
• Company overview
• Products and services
• Company strategy

• Softgenetics, LLC.
• Company overview
• Products and services
• Company strategy

• Strand Life Sciences
• Company overview
• Products and services
• Company strategy

• Synamatix Sdn Bhd
• Company overview
• Products and services
• Company strategy

• Teranode Corporation
• Company overview
• Products and services
• Company strategy

• Tibco Spotfire
• Company overview
• Products and services
• Company strategy

• Tripos International
• Company overview
• Products and services
• Company strategy

Chapter 9 - Appendix

• Index

List of Figures

• Figure 1.1: Bioinformatics components
• Figure 1.2: Bioinformatics market segmentation
• Figure 1.3: Market transition impacting bioinformatics market
• Figure 1.4: Role of bioinformatics in drug development process
• Figure 1.5: Comparative analysis of the bioinformatics application market
• Figure 1.6: Relative importance of bioinformatic tool features (2009 vs 2014)
• Figure 1.7: Market size versus growth in the bioinformatic tools market
• Figure 1.8: Market size versus growth in the bioinformatic services market
• Figure 1.9: Patents approved by technology (%), 2004 vs 2008
• Figure 1.10: Patents approved by company, 2004-08
• Figure 1.11: Regional approval of patents, 2004 vs 2008
• Figure 2.12: Strategic focus of bioinformatics companies, 2008-09
• Figure 3.13: Bioinformatic tools market dynamics
• Figure 3.14: Level of market attractiveness of bioinformatic tools
• Figure 3.15: Sequence analysis process and application of bioinformatic tools
• Figure 4.16: Bioinformatics content/database market dynamics
• Figure 5.17: Bioinformatics services market dynamics
• Figure 5.18: Level of attractiveness of the bioinformatics services market
• Figure 6.19: Regional distribution of bioinformatics applications market, 2009 and 2014
• Figure 6.20: Global scenario for molecular medicine
• Figure 6.21: Level of market attractiveness for other bioinformatic applications
• Figure 7.22: Market revenues for Asia, 2008 vs 2014
• Figure 7.23: Comparative impact of business environment (India and China), 2009
• Figure 7.24: Indian bioinformatics market structure
• Figure 7.25: Source of revenue for Indian bioinformatics firms
• Figure 7.26: Major opportunities for Indian IT market players
• Figure 7.27: Business opportunities in India and China
• Figure 7.28: Key trends impacting India and China

List of Tables

• Table 1.1: Global bioinformatics market by submarket, 2007 - 14($m)
• Table 2.2: Recent mergers and acquisitions, 2008 - 09
• Table 2.3: New product, technology or service launches, 2008 - 09
• Table 2.4: New product, technology or service launches, 2008 - 09 (contd 1)
• Table 2.5: New product, technology or service launches, 2008 - 09 (contd 2)
• Table 2.6: New product, technology or service launches, 2008 - 09 (contd 3)
• Table 3.7: Global bioinformatic tools market by product, 2007 - 14 ($m)
• Table 3.8: Bioinformatic tools market by region, 2007 - 14 ($m)
• Table 3.9: Global sequence analysis tools market by product function,
• Table 3.10: Sequence analysis tools market by region, 2007 - 14 ($m)
• Table 3.11: Global DNA sequence analysis tools market by product function, 2007 - 14 ($m)
• Table 3.12: DNA sequence analysis tools market by region, 2007 - 14 ($m)
• Table 3.13: Sequence alignment market by region, 2007 - 14 ($m)
• Table 3.14: Gene detection market by region, 2007 - 14 ($m)
• Table 3.15: Market for restriction and detection of repeats and unusual patterns by region, 2007 - 14 ($m)
• Table 3.16: Transcriptional elements detection market by region, 2007 - 14 ($m)
• Table 3.17: tRNA detection market by region, 2007 - 14 ($m)
• Table 3.18: Global protein function assignment market by product function, 2007 - 14 ($m)
• Table 3.19: Protein function assignment market by region, 2007 - 14 ($m)
• Table 3.20: Protein-protein interactions tools market by region, 2007 - 14 ($m)
• Table 3.21: Market for pattern, motif, profiles, domains and families search by region, 2007 - 14 ($m)
• Table 3.22: Search, computation and analysis of pathways market by region, 2007 - 14 ($m)
• Table 3.23: Protein annotation market by region, 2007 - 14 ($m)
• Table 3.24: Automatic alerts for related new sequences market by region, 2007 - 14 ($m)
• Table 3.25: Global 3D structure analysis and modeling market by product function, 2007 - 14 ($m)
• Table 3.26: 3D structure analysis and modeling market by region, 2007 - 14 ($m)
• Table 3.27: 3D viewers market by region, 2007 - 14 ($m)
• Table 3.28: 3D homology modeling market by region, 2007 - 14 ($m)
• Table 3.29: 3D analysis market by region, 2007 - 14 ($m)
• Table 3.30: RNA analysis tool market by region, 2007 - 14 ($m)
• Table 3.31: Microarray data analysis market by region, 2007 - 14 ($m)
• Table 3.32: Global phylogenetic analysis market by product function, 2007 - 14 ($m)
• Table 3.33: Phylogenetic analysis market by region, 2007 - 14 ($m)
• Table 3.34: Multiple sequence alignment market by region, 2007 - 14 ($m)
• Table 3.35: Organism classification market by region, 2007 - 14 ($m)
• Table 3.36: Sequence alignment tools market by product function, 2007 - 14 ($m)
• Table 3.37: Sequence alignment tools market by region, 2007 - 14 ($m)
• Table 3.38: Sequence analysis (alignment) tools market by product function, 2007 - 14 ($m)
• Table 3.39: Sequence analysis (alignment) tools market by region, 2007 - 14 ($m)
• Table 3.40: Multiple sequence alignment market by region, 2007 - 14 ($m)
• Table 3.41: Phylogenetic tree building market by region, 2007 - 14 ($m)
• Table 3.42: Consensus sequence and translation by region, 2007 - 14 ($m)
• Table 3.43: Lab end-sequence analysis market by product function, 2007 - 14 ($m)
• Table 3.44: Lab end-sequence analysis by region, 2007 - 14 ($m)
• Table 3.45: Primer design market by region, 2007 - 14 ($m)
• Table 3.46: Cloning market by region, 2007 - 14 ($m)
• Table 3.47: Contig assembly market by region, 2007 - 14 ($m)
• Table 3.48: Sequence manipulation tools market by product function, 2007 - 14 ($m)
• Table 3.49: Sequence manipulation tools market by region, 2007 - 14 ($m)
• Table 3.50: Sequence analysis (including sequence manipulation) market by region, 2007 - 14 ($m)
• Table 3.51: Sequence manipulation market by region, 2007 - 14 ($m)
• Table 3.52: Format conversion market by region, 2007 - 14 ($m)
• Table 3.53: Random sequences market by region, 2007 - 14 ($m)
• Table 3.54: Global structural analysis tools market by product function, 2007 - 14 ($m)
• Table 3.55: Structural analysis tools market by region, 2007 - 14 ($m)
• Table 3.56: Global sequence visualization market by product, 2007 - 14 ($m)
• Table 3.57: Sequence visualization market by region, 2007 - 14 ($m)
• Table 3.58: 3D protein structure market by region, 2007 - 14 ($m)
• Table 3.59: Dot plots and others market by region, 2007 - 14 ($m)
• Table 3.60: Graphical and phylogenetic tree viewer and editor market by region, 2007 - 14 ($m)
• Table 3.61: Primary sequence analysis market by region, 2007 - 14 ($m)
• Table 3.62: Physicochemical property alignment market by region, 2007 - 14 ($m)
• Table 3.63: Alignment tools market by region, 2007 - 14 ($m)
• Table 3.64: Tools to predict secondary structure sequence market by region, 2007 - 14 ($m)
• Table 3.65: Global other tools market by product, 2007 - 14 ($m)
• Table 3.66: Other tools market by region, 2007 - 14 ($m)
• Table 3.67: Visualization tools market by product, 2007 - 14 ($m)
• Table 3.68: Visualization tools market by region, 2007 - 14 ($m)
• Table 3.69: Database viewers market by region, 2007 - 14 ($m)
• Table 3.70: Sequence viewers market by region, 2007 - 14 ($m)
• Table 3.71: Molecular viewers market by region, 2007 - 14 ($m)
• Table 3.72: Physical mapping software market by region, 2007 - 14 ($m)
• Table 4.73: Global content/database market by product, 2007 - 14 ($m)
• Table 4.74: Content/database market by region, 2007 - 14 ($m)
• Table 4.75: Global specialized database market by product, 2007 - 14 ($m)
• Table 4.76: Specialized database market by region, 2007 - 14 ($m)
• Table 4.77: Specialized sequence databases market by region, 2007 - 14 ($m)
• Table 4.78: Global genome databases market by product, 2007 - 14 ($m)
• Table 4.79: Genome databases market by region, 2007 - 14 ($m)
• Table 4.80: Collections market by region, 2007 - 14 ($m)
• Table 4.81: Model organism databases market by region, 2007 - 14 ($m)
• Table 4.82: Global specialized protein databases market by product, 2007 - 14 ($m)
• Table 4.83: Specialized protein databases market by region,
• Table 4.84: Proteome databases market by region, 2007 - 14 ($m)
• Table 4.85: Protein classification databases market by region, 2007 - 14 ($m)
• Table 4.86: Specific protein family databases market by region, 2007 - 14 ($m)
• Table 4.87: Specialized structural databases market by region, 2007 - 14 ($m)
• Table 4.88: Microarray databases market by region, 2007 - 14 ($m)
• Table 4.89: Pathway databases market by region, 2007 - 14 ($m)
• Table 4.90: 2D-PAGE databases market by region, 2007 - 14 ($m)
• Table 4.91: Global general database market by product, 2007 - 14 ($m)
• Table 4.92: General database market by region, 2007 - 14 ($m)
• Table 4.93: Primary sequence databases market by region, 2007 - 14 ($m)
• Table 4.94: Protein sequence databases market by region, 2007 - 14 ($m)
• Table 4.95: 3D structure databases market by region, 2007 - 14 ($m)
• Table 4.96: Carbohydrate databases market by region, 2007 - 14 ($m)
• Table 5.97: Global services market by product function, 2007 - 14 ($m)
• Table 5.98: Services market by region, 2007 - 14 ($m)
• Table 5.99: Global data analysis services market by product function, 2007 - 14 ($m)
• Table 5.100: Data analysis services market by region, 2007 - 14 ($m)
• Table 5.101: Genomics data analysis market services by region, 2007 - 14 ($m)
• Table 5.102: Proteomics data analysis services market by region, 2007 - 14 ($m)
• Table 5.103: Microarray data analysis services market by region, 2007 - 14 ($m)
• Table 5.104: Modeling & computational bioinformatics services market by region, 2007 - 14 ($m)
• Table 5.105: Global sequencing services market by product function, 2007 - 14 ($m)
• Table 5.106: Sequencing services market by region, 2007 - 14 ($m)
• Table 5.107: High-throughput sequencing market by region, 2007 - 14 ($m)
• Table 5.108: Multiple sequence alignment market by region, 2007 - 14 ($m)
• Table 5.109: Resequencing services market by region, 2007 - 14 ($m)
• Table 5.110: Primer walking market by region, 2007 - 14 ($m)
• Table 5.111: Expression profile clustering and sequence pattern market by region, 2007 - 14 ($m)
• Table 5.112: Shotgun sequencing (bacterial artificial chromosomes and cosmids) market by region, 2007 - 14 ($m)
• Table 5.113: Global database management market by product function, 2007 - 14 ($m)
• Table 5.114: Database management market by region, 2007 - 14 ($m)
• Table 5.115: Conception and realization market by region, 2007 - 14 ($m)
• Table 5.116: User interface development market by region, 2007 - 14 ($m)
• Table 5.117: Maintenance market by region, 2007 - 14 ($m)
• Table 5.118: Backup system market by region, 2007 - 14 ($m)
• Table 5.119: Migration market by region, 2007 - 14 ($m)
• Table 5.120: Other services market by region, 2007 - 14 ($m)
• Table 5.121: Other services market by region, 2007 - 14 ($m)
• Table 5.122: Security system market by region, 2007 - 14 ($m)
• Table 5.123: Data-mining services by region, 2007 - 14 ($m)
• Table 5.124: Infrastructure integration services market by region, 2007 - 14 ($m)
• Table 5.125: Knowledge management market by region, 2007 - 14 ($m)
• Table 6.126: Global applications market by product segment, 2007 - 14 ($m)
• Table 6.127: Global molecular medicine market by product segment, 2007 - 14 ($m)
• Table 6.128: Global preventive medicine market by product segment, 2007 - 14 ($m)
• Table 6.129: Global gene therapy market by product segment, 2007 - 14 ($m)
• Table 6.130: Global drug development market by product function, 2007 - 14 ($m)
• Table 6.131: Global other applications market by product function, 2007 - 14 ($m)
• Table 7.132: Market forecast for bioinformatics by region, 2007 - 14 ($m)
• Table 7.133: North American bioinformatics market, 2007 - 14 ($m)
• Table 7.134: European bioinformatics market, 2007 - 14 ($m)
• Table 7.135: Asian bioinformatics market, 2007 - 14 ($m)
• Table 7.136: RoW bioinformatics market, 2007 - 14 ($m)
• Table 9.137: US bioinformatics patents
• Table 9.138: US bioinformatics patents (contd 1)
• Table 9.139: US bioinformatics patents (contd 2)
• Table 9.140: US bioinformatics patents (contd 3)
• Table 9.141: European bioinformatics patents
• Table 9.142: European bioinformatics patents (contd 1)
• Table 9.143: European bioinformatics patents (contd 2)
• Table 9.144: Japanese bioinformatics patents
• Table 9.145: Japanese bioinformatics patents (contd 1)
• Table 9.146: Japanese bioinformatics patents (contd 2)

Related Reports